HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphotoxin-alpha (Lymphotoxin)

A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR.
Also Known As:
Lymphotoxin; Tumor Necrosis Factor beta; Lymphotoxin-alpha3; Soluble Lymphotoxin-alpha; alpha-Lymphotoxin; Lymphotoxin alpha; Lymphotoxin alpha3; Lymphotoxin-alpha, Soluble; Soluble Lymphotoxin alpha; alpha Lymphotoxin; TNF Superfamily, Member 1; TNF-beta; Tumor Necrosis Factor Ligand Superfamily Member 1; Tumor Necrosis Factor-beta
Networked: 1300 relevant articles (14 outcomes, 129 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fu, Yang-Xin: 28 articles (12/2018 - 06/2002)
2. Ware, Carl F: 16 articles (01/2020 - 07/2004)
3. Browning, Jeffrey L: 13 articles (01/2017 - 07/2003)
4. Pfeffer, Klaus: 10 articles (01/2017 - 05/2003)
5. Nedospasov, Sergei A: 9 articles (03/2011 - 02/2004)
6. Zhu, Mingzhao: 8 articles (01/2019 - 10/2009)
7. Grogan, Jane L: 8 articles (12/2018 - 07/2009)
8. Heikenwalder, Mathias: 8 articles (01/2017 - 12/2008)
9. Tumanov, Alexei V: 7 articles (01/2021 - 02/2004)
10. Hehlgans, Thomas: 7 articles (01/2020 - 05/2003)

Related Diseases

1. Infections
2. Inflammation (Inflammations)
3. Melanoma (Melanoma, Malignant)
4. Neoplasms (Cancer)
5. Disease Progression

Related Drugs and Biologics

1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2. Proteins (Proteins, Gene)
3. Immunoglobulins (Immunoglobulin)
4. Infliximab (Remicade)
5. Glutamic Acid (Glutamate)
6. N-Methylaspartate (NMDA)
7. Fc Receptors (Fc Receptor)
8. Cytokines
9. Interleukin-6 (Interleukin 6)
10. Interleukins

Related Therapies and Procedures

1. Therapeutics
2. Vitrectomy
3. Ligation
4. Immunotherapy
5. Injections